BrainsWay Ltd. (BWAY)

$2.09

-0.01 (-0.48%)
Rating:
Recommendation:
-
Symbol BWAY
Price $2.09
Beta 0.195
Volume Avg. 0.15M
Market Cap 35.901M
Shares () -
52 Week Range 1.64-9.18
1y Target Est -
DCF Unlevered BWAY DCF ->
DCF Levered BWAY LDCF ->
ROE -20.37% Sell
ROA -16.60% Sell
Operating Margin -
Debt / Equity 38.35% Neutral
P/E -
P/B 0.72 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest BWAY news


Dr. Christopher R. von Jako Ph.D.
Healthcare
Medical Devices
NASDAQ Global Market

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.